BUSINESS

PDO Banking

The Largest PDO Bank in Asia

GBCC's cancer PDOs are established from patient lesions and normal tissues
such as lung, colon, and stomach cancer.
PDO characterization data including genome analysis and drug reactivity are
systematically managed in an integrated system.

GBCC has secured valuable culture technology through collaborations with world-leading organizations and experts in the organoid field, establishing organoids with high degree of similarity to patient's genetic profile.

PDO is a core asset of GBCC for drug efficacy evaluation and target discovery, and we are improving quality and diversity through ongoing joint research with major hospitals locally and abroad.